 |
|
|
|
|
|
|
| Article 1 to 4 out of 4 concerning Becton, Dickinson and Company
|
-
BD Completes Acquisition of TriPath Imaging
(22 Dec 2006)
Expands Presence in Cancer Diagnostics Market
BD (Becton, Dickinson and Company) announced the completion of its acquisition of TriPath Imaging. The acquisition was finalized in accordance with terms originally disclosed in an announcement issued by BD on September 8, 2006.According to the ...
-
BD to Acquire TriPath Imaging, Inc.
(12 Sep 2006)
Advances BD's position in cancer diagnostics
BD (Becton, Dickinson and Company) announced that it has signed a definitive agreement to acquire the 93.5% of the outstanding shares of TriPath Imaging which BD does not currently own, for a cash purchase price of $9.25 per share, or approximately ...
-
BD Makes Filing to Report Bid to Acquire TriPath Imaging, Inc.
(21 Aug 2006)
BD (Becton, Dickinson and Company) filed with the Securities and Exchange Commission a Statement on Schedule 13D setting forth a proposal it made to acquire for a cash purchase price of $9.25 per share, or approximately $350 million, the ...
-
Research Shows CD4 Testing Cost-Effective for HIV Patients in Areas Lacking Access to Second-Line ARV Treatments
(15 Aug 2006)
BD (Becton, Dickinson and Company) announced the release of a study by researchers from the Johns Hopkins Bloomberg School of Public Health at the XVI International AIDS Conference (AIDS 2006) that demonstrated conducting CD4 tests is a ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon